Also known as آسٹیوپوروسس مینجمنٹ
Endocrinologist
M.B.B.S., F.C.P.S., Fellowship Endocrinology and Diabetes
Internal Medicine Specialist
MBBS, MRCP (UK), MRCGP (UK), MRCPS (Glasgow), CCT (UK)
Internal Medicine Specialist
MBBS, MRCP (UK), MRCGP (UK), MRCPS (Glasgow), CCT (UK)
Internal Medicine Specialist
MBBS, Specialty Certificate in Endocrine and Diabetes, MRCP (Dublin), MRCP (London)
Internal Medicine Specialist
MBBS, Specialty Certificate in Endocrine and Diabetes, MRCP (Dublin), MRCP (London)
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Internal Medicine Specialist
MBBS, MRCP (London), MRCP (UK), FCPS (Pak)
Internal Medicine Specialist
MBBS, MCPS
Diabetologist
MBBS, M.Sc (Diabetes & Endocrinology)
Internal Medicine Specialist
MBBS, DTCD, FCPS (Medicine), MCPS
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, MCPS
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures